Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Immunosuppressive Therapy of Sarcoidosis on Lymphoma Development

NCT07343401 is registered in ClinicalTrials.gov with Alexandria University as lead sponsor.

NCT NCT07343401
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07343401 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Immunosuppressive Therapy of Sarcoidosis on Lymphoma Development
Lead sponsor
Alexandria University
Phase
Observational
Overall status
Completed
Start date
August 1, 2025
Completion date
January 1, 2026
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sarcoidosis lung